FOXO TECHNOLOGIES INC. Increase (Decrease) in Other Current Assets
FOXO TECHNOLOGIES INC. (FOXO) reported Increase (Decrease) in Other Current Assets of $40.69 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2026-08-14
- FOXO TECHNOLOGIES INC. increase (decrease) in other current assets for the quarter ending 2026-06-30 was -$4.15K.
- FOXO TECHNOLOGIES INC. increase (decrease) in other current assets for the quarter ending 2026-03-31 was $44.84K, a 20.01% decline year-over-year.
- FOXO TECHNOLOGIES INC. increase (decrease) in other current assets for the quarter ending 2025-12-31 was $11.35K.
- FOXO TECHNOLOGIES INC. increase (decrease) in other current assets for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- FOXO TECHNOLOGIES INC. increase (decrease) in other current assets for fiscal 2025 was $65.80K.
- FOXO TECHNOLOGIES INC. increase (decrease) in other current assets for fiscal 2024 was -$74.23K.
- FOXO TECHNOLOGIES INC. increase (decrease) in other current assets for fiscal 2023 was -$4.61K, a 105.07% decline from fiscal 2022.
- FOXO TECHNOLOGIES INC. increase (decrease) in other current assets for fiscal 2022 was $91.00K, a 1416.67% increase from fiscal 2021.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 3 month as first filed | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 6 month as first filed | Increase (Decrease) in Other Current Assets 9 month | Increase (Decrease) in Other Current Assets 9 month as first filed | Increase (Decrease) in Other Current Assets 12 month | Increase (Decrease) in Other Current Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$4.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $40.69K 10-Q · filed 2026-08-14 | $52.05K derived: sum of 3 quarters · filed 2026-08-14 | $52.05K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $44.84K 10-Q · filed 2026-05-15 | $56.20K derived: sum of 2 quarters · filed 2026-05-15 | $56.20K derived: sum of 3 quarters · filed 2026-05-15 | $54.58K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | $11.35K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $11.35K derived: sum of 2 quarters · filed 2026-04-15 | $9.73K derived: sum of 3 quarters · filed 2026-08-14 | $65.80K 10-K · filed 2026-04-15 | ||||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$1.62K derived: sum of 2 quarters · filed 2026-08-14 | $54.45K 10-Q · filed 2025-11-10 | -$15.38K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | -$1.62K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $54.45K 10-Q · filed 2026-08-14 | -$15.38K derived: sum of 3 quarters · filed 2026-08-14 | -$7.01K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | $56.07K 10-Q · filed 2026-05-15 | -$13.76K derived: sum of 2 quarters · filed 2026-05-15 | -$5.39K derived: sum of 3 quarters · filed 2026-05-15 | -$13.03K derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | -$69.83K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$61.45K derived: sum of 2 quarters · filed 2026-04-15 | -$69.10K derived: sum of 3 quarters · filed 2026-04-15 | -$74.23K 10-K · filed 2026-04-15 | ||||
| 2024-09-30 | $8.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $732.00 derived: sum of 2 quarters · filed 2025-11-10 | -$4.40K 10-Q · filed 2025-11-10 | -$4.00K 10-Q · filed 2024-11-19 | -$6.01K derived: sum of 4 quarters · filed 2025-11-10 | |||
| 2024-06-30 | -$7.64K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2025-08-19 | -$12.77K 10-Q · filed 2025-08-19 | -$13.00K 10-Q · filed 2024-08-19 | -$14.38K derived: sum of 3 quarters · filed 2025-08-19 | -$8.38K derived: sum of 4 quarters · filed 2025-08-19 | |||
| 2024-03-31 | -$5.13K 10-Q/A · filed 2025-08-19 | -$5.00K 10-Q · filed 2024-06-28 | -$6.74K derived: sum of 2 quarters · filed 2025-08-19 | -$743.00 derived: sum of 3 quarters · filed 2025-08-19 | -$2.74K derived: sum of 4 quarters · filed 2025-08-19 | |||
| 2023-12-31 | -$1.61K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $4.39K derived: sum of 2 quarters · filed 2025-04-15 | $2.39K derived: sum of 3 quarters · filed 2025-04-15 | -$4.61K 10-K · filed 2025-04-15 | -$5.00K 10-K · filed 2024-06-06 | |||
| 2023-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-19 | $4.00K derived: sum of 2 quarters · filed 2024-11-19 | -$3.00K 10-Q · filed 2024-11-19 | |||||
| 2023-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | -$9.00K 10-Q · filed 2024-08-19 | ||||||
| 2023-03-31 | -$7.00K 10-Q · filed 2024-06-28 | |||||||
| 2022-12-31 | $91.00K 10-K · filed 2024-06-06 | |||||||
| 2021-12-31 | $6.00K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |